Institute of Arthritis Research

The Institute of Arthritis Research (IAR) is a clinical research organization and biotechnology company based in Idaho Falls, Idaho. Founded and directed by Dr. Craig D. Scoville, the institute has over 30 years of experience and has conducted more than 150 sponsor-initiated clinical trials for major pharmaceutical companies, including Pfizer, AbbVie, and Genentech. Beyond its role as a clinical trial site, IAR conducts proprietary research in the fields of immunology, sepsis, and autoimmune diseases. The company holds patents for immunologically active polypeptides and is currently sponsoring clinical research into the use of Tdap vaccinations to reduce the incidence of preeclampsia. IAR also focuses on biomarker discovery, particularly investigating the role of the renin-angiotensin system in the pathogenesis of rheumatoid arthritis.